A Study of PLX2853 in Advanced Malignancies.

Clinical trial NCT03297424 · COMPLETED

Trial details

NCT number: NCT03297424
Sponsor: Opna Bio LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Small Cell Lung Cancer Uveal Melanoma Ovarian Clear Cell Carcinoma Non-Hodgkin Lymphoma Advanced Malignancies Solid Tumor Diffuse Large B Cell Lymphoma Follicular Lymphoma

Start date: 2017-09-12
Primary completion: 2021-06-07
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.